ArticleClinical and experimental medicine2025
New inflammatory markers associated with disease activity in patients with antineutrophil cytoplasmic Antibody-associated vasculitis.
Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Inflammatory blood count ratios discriminate disease activity and remain persistently elevated during glucocorticoid-free remission in ANCA-associated vasculitis.Clinical and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives To explore the relationship between the levels of new inflammatory markers (MLR, PLR, NLR, SII and SIRI) and the disease activity in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Patients and methods In this study, 974 patients with AAV were included. On the basis of the Birmingham vasculitis activity score (BVAS), the patients were divided into high-disease-activity (BVAS ≥ 12) and low-disease-activity (BVAS < 12) groups. The new inflammatory markers in the two groups were compared. Multivariate linear regression analysis was performed to assess the influencing factors of disease activity in patients with AAV. Results The levels of MLR, NLR, PLR, SII, and SIRI in the high-disease-activity group significantly increased (P < 0.05) compared with those in the low-disease-activity group, and some indictors (SII and SIRI) recovered after AAV disease-inducing remission. Furthermore, the MLR, NLR, SII, SIRI, and BVAS of the patients with AAV with renal involvement significantly increased (P < 0.05). Spearman correlation analysis showed that these new inflammation markers were positively correlated with BVAS and traditional inflammatory markers, such as C-reactive protein and erythrocyte sedimentation rate (all P < 0.001). Multivariate linear regression analysis revealed that MLR, NLR and SIRI were independent risk factors for high disease activity (P < 0.05). Conclusion These nonspecific inflammatory indicators, derived from routine blood tests, may serve as potential supportive markers for assessing disease activity in patients with AAV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.